Ian A. Cook

Direttore Tecnico/Scientifico/R&S presso NeuroSigma, Inc.

64 anni

Consumer Services

Health Technology

Posizioni attive di Ian A. Cook

Società	Posizione	Inizio	Fine
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Direttore Tecnico/Scientifico/R&S	01/01/2014	-
Henry Samueli School of Engineering & Applied Science	Corporate Officer/Principal	01/07/2013	-
David Geffen School of Medicine	Corporate Officer/Principal	01/07/2010	-
Semel Institute For Neuroscience & Human Behavior	Corporate Officer/Principal	01/01/2007	-

Princeton University	Undergraduate Degree
Yale School of Medicine	Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Settori

Consumer Services	6
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Health Technology

Aziende private

Health Technology